Benchmark Genetics is pleased to announce the appointment of Jon Crowther as Chief Financial Officer (CFO), marking a new chapter in the company’s financial leadership as it begins life as an independent company under Novo Holdings.
Jon is a chartered accountant trained at PwC and has served as Finance Director of Benchmark Genetics since its formation in 2014. Based in the UK, he brings a wealth of experience from senior finance roles across multiple sectors, including nine years as UK Controller at GE. Over the past decade, Jon has played a key role in the development of Benchmark Genetics, helping shape a financially robust foundation for sustainable growth.
As CFO, Jon is responsible for all aspects of financial management across the company’s global operations. He leads finance teams in Norway, Iceland, Chile, the USA, the UK, and Colombia, and thrives on the international scope of the role.
A key part of his current focus is overseeing the transition of Benchmark Genetics from Benchmark Holdings to new ownership under Novo Holdings, a move that Jon believes positions the company for long-term success.
The acquisition by Novo Holdings puts us in a unique position to plan for the long term,- Jon says. It’s great to move from the short-term reporting horizon of a publicly-quoted company to the longer-term horizon of a PE-backed business. Benchmark Genetics is a business which will realise its true value under the ownership of Novo Holdings.
With Jon’s leadership and deep understanding of the business, Benchmark Genetics is well-positioned to deliver on its strategic ambitions and continue to provide world-leading genetic solutions for aquaculture.
